Scalper1 News
Shares of specialty drugmaker Shire plummeted 23% on the stock market today after word got out late Tuesday that big pharma AbbVie is reconsidering its $55 billion buyout of the company. Shire (SHPG) confirmed the reports Wednesday morning with a statement saying that AbbVie ‘s (ABBV) board intends to “consider whether to withdraw or modify its recommendation in light of the impact of the U.S. Treasury Notice” on Sept. 22. The Treasury Notice is Scalper1 News
Scalper1 News